Aclarubicin: 20 mg/m^2 on days 1, 3, and 5

2 trials

Sponsors

The Fifth Medical Center of the General Hospital of the People's Liberation Army, The Fifth Medical Center of the General Hospital of the People's Liberation Army.

Conditions

Acute Myeloid Leukemia (AML)

Phase 2

Key Technical Research on CACAG Combined with Venetoclax for the Treatment of Elderly Patients with Primary Acute Myeloid Leukemia

RecruitingChiCTR2500095795

The Fifth Medical Center of the General Hospital of the People's Liberation ArmyAcute Myeloid Leukemia (AML)

Start: 2024-12-18Updated: 2025-01-27

Unknown Phase

A multicenter, prospective, randomized controlled study of the standard "3+7" regimen versus Venetoclax combined with CACAG regimen in newly diagnosed adult patients with intermediate- and high-risk acute myeloid leukemia

RecruitingChiCTR2500101476

The Fifth Medical Center of the General Hospital of the People's Liberation Army.Acute Myeloid Leukemia (AML)

Start: 2024-05-18Updated: 2025-04-28